Literature DB >> 16457865

Aflatoxin M1 absorption and cytotoxicity on human intestinal in vitro model.

F Caloni1, A Stammati, G Friggè, I De Angelis.   

Abstract

Aflatoxin M1 (AFM1) is the principal hydroxylated Aflatoxin B1 (AFB1) metabolite and is detected in milk of mammals, after consumption of feed contaminated with AFB1. As it is classified as probable human carcinogen (group 2B of the IARC), most countries have regulated its maximum allowed levels in milk in order to reduce AFM1 risk (50 ng/kg the EU and 500 ng/kg in the USA). It was demonstrated that if AFB1 must be converted into its reactive epoxide to exert its effects, and the protein binding may play an important role in its cytotoxicity. Conversely, the AFM1 epoxidation in human liver microsomes is very limited and studies with human cell line (MCL5), expressing or not expressing cytochrome P450 enzymes, demonstrated a direct toxic potential of AFM1 in absence of metabolic activation. For this reason, while AFM1 is generally considered a detoxification product of AFB1 relatively to carcinogenicity and mutagenicity property, this is not always true for cytotoxicity activity. Aim of this work is to evaluate the intestinal absorption of AFM1 using a human in vitro model, the Caco-2 cell line. Either the parental Caco-2 cell line or its derived clone TC7, with higher metabolic competence, have been used. They were treated with different concentrations of AFM1, that mirror the milk contamination level (0.3-32 nM corresponding to 10-10,000 ng/kg), either in undifferentiated or in differentiated phase of growth. After 48 h of treatment in serum free medium, a dose dependent absorption of AFM1 has been detected in both cell lines, especially in differentiated cells, while, no appreciable effects on cell viability were observed, except for a general cellular suffering, revealed by LDH release, particularly evident in the undifferentiated cells. As well, no metabolites or AFM1 conjugates have been detected. The present results may be crucial for the evaluation of human risk to AFM1 exposure, in particular for children's population, due to their large use of milk and derivatives.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16457865     DOI: 10.1016/j.toxicon.2005.12.003

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  10 in total

1.  Aflatoxin M₁ in breast milk of nursing Sudanese mothers.

Authors:  Amin O Elzupir; Abdel Rouf A Abas; M Hemmat Fadul; Abueliz K Modwi; Nima M I Ali; Afaf F F Jadian; Nuha Abd A Ahmed; Smah Y A Adam; Nousiba A M Ahmed; Arwa A A Khairy; Eltahir A G Khalil
Journal:  Mycotoxin Res       Date:  2012-03-01       Impact factor: 3.833

2.  Transport of Aflatoxin M(1) in Human Intestinal Caco-2/TC7 Cells.

Authors:  Francesca Caloni; Cristina Cortinovis; Fabiola Pizzo; Isabella De Angelis
Journal:  Front Pharmacol       Date:  2012-06-11       Impact factor: 5.810

Review 3.  AFM₁ in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination.

Authors:  Laura Giovati; Walter Magliani; Tecla Ciociola; Claudia Santinoli; Stefania Conti; Luciano Polonelli
Journal:  Toxins (Basel)       Date:  2015-10-23       Impact factor: 4.546

4.  Higher Levels of Aflatoxin M1 Contamination and Poorer Composition of Milk Supplied by Informal Milk Marketing Chains in Pakistan.

Authors:  Naveed Aslam; Muhammad Yasin Tipu; Muhammad Ishaq; Ann Cowling; David McGill; Hassan Mahmood Warriach; Peter Wynn
Journal:  Toxins (Basel)       Date:  2016-12-05       Impact factor: 4.546

5.  A comparative study of procedures for binding of aflatoxin M1 to Lactobacillus rhamnosus GG.

Authors:  Jean Claude Assaf; Ali Atoui; André El Khoury; Ali Chokr; Nicolas Louka
Journal:  Braz J Microbiol       Date:  2017-08-06       Impact factor: 2.476

Review 6.  The intestinal barrier as an emerging target in the toxicological assessment of mycotoxins.

Authors:  Peyman Akbari; Saskia Braber; Soheil Varasteh; Arash Alizadeh; Johan Garssen; Johanna Fink-Gremmels
Journal:  Arch Toxicol       Date:  2016-07-14       Impact factor: 5.153

Review 7.  Aflatoxin B1 and M1: Biological Properties and Their Involvement in Cancer Development.

Authors:  Silvia Marchese; Andrea Polo; Andrea Ariano; Salvatore Velotto; Susan Costantini; Lorella Severino
Journal:  Toxins (Basel)       Date:  2018-05-24       Impact factor: 4.546

Review 8.  Assorted Methods for Decontamination of Aflatoxin M1 in Milk Using Microbial Adsorbents.

Authors:  Jean Claude Assaf; Sahar Nahle; Ali Chokr; Nicolas Louka; Ali Atoui; André El Khoury
Journal:  Toxins (Basel)       Date:  2019-05-29       Impact factor: 4.546

9.  Aflatoxin M1 Contamination Levels in Cheeses Sold in Isfahan Province, Iran.

Authors:  Ali Sharifzadeh; Payam Ghasemi-Dehkordi; Mohsen Foroughi; Elham Mardanpour-Shahrekordi; Shahin Ramazi
Journal:  Osong Public Health Res Perspect       Date:  2017-08-31

10.  Aflatoxin B1 and Aflatoxin M1 Induce Compromised Intestinal Integrity through Clathrin-Mediated Endocytosis.

Authors:  Yanan Gao; Xiaoyu Bao; Lu Meng; Huimin Liu; Jiaqi Wang; Nan Zheng
Journal:  Toxins (Basel)       Date:  2021-03-02       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.